TAKEDA PHARMACEUTICAL CO LTD has an estimated net worth of $295 Million. This is based on reported shares across multiple companies, which include Calithera Biosciences, Inc., Xilio Therapeutics, Inc., Theseus Pharmaceuticals, Inc., Day One Biopharmaceuticals, Inc., Translate Bio, Inc., Ovid Therapeutics Inc., BiomX Inc., Phathom Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc., Cortexyme, Inc., Molecular Templates, Inc., HilleVax, Inc., and Myovant Sciences Ltd..

2022 was TAKEDA PHARMACEUTICAL CO LTD's most active year for acquiring shares with 5 total transactions. TAKEDA PHARMACEUTICAL CO LTD's most active month to acquire stocks was the month of June. 2021 was TAKEDA PHARMACEUTICAL CO LTD's most active year for disposing of shares, totalling 58 transactions. TAKEDA PHARMACEUTICAL CO LTD's most active month to dispose stocks was the month of April. 2018 saw TAKEDA PHARMACEUTICAL CO LTD paying a total of $138,543,068.75 for 7,420,625 shares, this is the most they've acquired in one year. In 2020 TAKEDA PHARMACEUTICAL CO LTD cashed out on 7,078,945 shares for a total of $146,169,557.13, their largest year based on trade value.